Web11 apr. 2024 · Concord Wealth Partners cut its holdings in AbbVie Inc. (NYSE:ABBV - Get Rating) by 35.6% during the fourth quarter, according to its most recent disclosure with … Web9 apr. 2024 · MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 …
ABBV Dividend Yield 2024, Date & History (AbbVie)
Web11 apr. 2024 · AbbVie stock price quote (NYSE: ABBV), historical charts, related news, stock analyst insights and more to help you make the right investing decisions. Web9 mrt. 2024 · Nine analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has give AbbVie Inc. (NYSE:ABBV - Get Rating) has been assigned … simply test me government approved
ABT Price Target 2024 Abbott Laboratories Analyst …
Web13 apr. 2024 · According to 34 analysts, the average rating for ABBV stock is "Buy." The 12-month stock price forecast is $167.15, which is an increase of 3.58% from the latest price. Price Target $167.15 ( 3.58% upside) Analyst Consensus: Buy Stock Forecasts News All Videos Press Releases Conversation Final Trades: Starbucks, Abbvie, … Web9 apr. 2024 · According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $161.12. AbbVie Stock Up 0.5 % ABBV stock opened at $161.55 on Friday.... Web9 apr. 2024 · AbbVie ( NYSE:ABBV - Get Rating) last issued its quarterly earnings data on Thursday, February 9th. The company reported $3.60 earnings per share for the quarter, beating analysts' consensus estimates of $3.54 by $0.06. AbbVie had a return on equity of 154.52% and a net margin of 20.39%. ray white rochedale village